Skip to main content
Clinical Trials/CTRI/2022/03/040881
CTRI/2022/03/040881
Not yet recruiting
Phase 3

A Clinical Study To Determine The Effectiveness Of Homoeopathic Constitutional Medicines In Lowering Fecal Calprotectin In Patients With Inflammatory Bowel Disease

Anju KS0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: K50- Crohns disease [regional enteritis]Health Condition 2: K51- Ulcerative colitis
Sponsor
Anju KS
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Anju KS

Eligibility Criteria

Inclusion Criteria

  • Diagnosed cases of IBD by GI endoscopy
  • Patient with signs and symptoms of IBD
  • Patients with elevated fecal calprotectin

Exclusion Criteria

  • Pregnant and lactating mother.
  • Patients who are diagnosed with immune deficiency diseases like AIDS, cancer, etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials